Bio-Rad Laboratories, Inc. (BIO)
269.85
-9.18
(-3.29%)
USD |
NYSE |
Mar 06, 16:00
269.80
-0.05
(-0.02%)
After-Hours: 20:00
Bio-Rad Laboratories Cash from Investing (TTM) : -189.70M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Agilent Technologies, Inc. | -393.00M |
| Bruker Corp. | -196.50M |
| Azenta, Inc. | -129.94M |
| Harvard Bioscience, Inc. | -1.73M |
| Bionano Genomics, Inc. | -13.76M |